Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Porcine Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) Monoclonal Antibody

Cat. No.VD8N235

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for cholinergic receptor nicotinic alpha 5. It is affinity purified by protein A. It can be applied to WB, IHC and ELISA assays of cholinergic receptor nicotinic alpha 5.

Specifications

Application WB; IHC; ELISA
Clonality Monoclonal
Classification Primary Antibody
Clone G5N48
Host Mouse
Target Species Porcine
Species Reactivity Porcine
Specificity Cholinergic Receptor Nicotinic Alpha 5
Isotype IgG2
Immunogen Recombinant protein of cholinergic receptor nicotinic alpha 5
Purification Protein A Purified
Concentration 2000 μg/mL
Conjugation Unconjugated
Preservative and Stabilizer 0.02% Sodium Azide
Buffer Phosphate Buffered Saline with 50% Glycerol, pH 7.3
Physical State Liquid

Target Information

Porcine cholinergic receptor nicotinic alpha 5 (pCHRNA5) is a subtype of the nicotinic acetylcholine receptors that are found in the nervous system of pigs. This receptor plays a significant role in synaptic transmission and is particularly involved in the modulation of neuronal excitability. pCHRNA5 is a pentameric transmembrane protein that, upon binding of acetylcholine, can initiate a series of intracellular signaling events. The presence of this receptor subtype contributes to the diversity of neuronal responses to cholinergic input and is implicated in cognitive functions, such as learning and memory.

Target Cholinergic Receptor Nicotinic Alpha 5
Target Synonym CHRNA5; LNCR2
Gene ID 100156023
UniProt ID A0A287AQW1

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Cingir Koker, Sahika, et al. "Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer." Plos one 13.12 (2018): e0208982.
Inquiry Basket